DnB Asset Management
VKTX icon

DnB Asset Management’s Viking Therapeutics VKTX Stock Holding History

DnB Asset Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$783K Sell
24,071
-3,305
-12% -$106K ﹤0.01% 670
2025
Q4 		$963K Buy
27,376
+4,655
+20% +$165K ﹤0.01% 639
2025
Q3 		$597K Buy
22,721
+1,853
+9% +$55.3K ﹤0.01% 664
2025
Q2 		$553K Buy
20,868
+1,373
+7% +$36.1K ﹤0.01% 644
2025
Q1 		$471K Sell
19,495
-11,171
-36% -$353K ﹤0.01% 660
2024
Q4 		$1.23M Buy
30,666
+15,209
+98% +$867K 0.01% 630
2024
Q3 		$979K Buy
15,457
+6,303
+69% +$370K ﹤0.01% 631
2024
Q2 		$485K Buy
9,154
+1,725
+23% +$113K ﹤0.01% 655
2024
Q1 		$609K Buy
+7,429
New +$331K ﹤0.01% 642

Other funds holding VKTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return